Cardiac Resynchronization Therapy Devices (CRT)

Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers.

Biotronik Announces FDA Approval of MultiPole Pacing
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 11, 2017

May 11, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval of the company's MultiPole...

Biotronik Launches First FDA-Approved CRM Devices with MRI AutoDetect Technology
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 10, 2017

May 10, 2017 —  Biotronik announced the availability of the first U.S. Food and Drug Administration (FDA)-approved...

Biotronik Receives FDA Approval for Sentus ProMRI Quadripolar Left Ventricular Lead
Technology | Leads Implantable Devices | May 09, 2017

May 9, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and the launch of Sentus ProMRI,...

Boston Scientific's Resonate X4 CRT-D system
Technology | Cardiac Resynchronization Therapy Devices (CRT) | May 09, 2017

May 9, 2017 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific’s Resonate family of...

WiSE CRT System is a wireless cardiac resynchonization therapy device with no lead wires

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional Cardiac Resynchronization Therapy (CRT) in heart failure patients.

News | Heart Failure | May 12, 2017

May 12, 2017 – New study proves safety of novel, wireless pacing system, WiSE CRT (Wireless Stimulation...

NICE Recommends Boston Scientific CRT-Ds With EnduraLife Battery Technology for Heart Failure Treatment
News | Cardiac Resynchronization Therapy Devices (CRT) | April 14, 2017

April 14, 2017 — The National Institute for Health and Care Excellence (NICE) recently issued medical technology...

Biotronik, Edora series, pacemakers, CRT-Ps
Technology | Cardiac Resynchronization Therapy Devices (CRT) | March 23, 2017

March 23, 2017 — Biotronik announced the European launch of the Edora series, its smallest series of...

Medtronic, CRT-D, REVERSE Trial analysis, cost-effectiveness, Michael R. Gold, JACC Heart Failure
News | Cardiac Resynchronization Therapy Devices (CRT) | March 07, 2017

March 7, 2017 — Medtronic plc recently announced an economic analysis of five-year data showing that patients with...

The FDA confirmed the cybersecurity vulnerabilities of St. Jude ICDs, pacemakes, implantable cardioverter defibrillators, CRT and other EP devices with wireless connections.
Feature | EP Lab | January 09, 2017 | Dave Fornell

January 9, 2017 — The U.S. Food and Drug Administration (FDA) issued a safety communication today concerning patient...

Medtronic, Claria MRI Quad CRT-D SureScan, FDA approval
Technology | Cardiac Resynchronization Therapy Devices (CRT) | November 15, 2016

November 15, 2016 — Medtronic plc  has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI ...

SJM, st. Jude Medical, FDA recall, Battery depletion, Recalls ICDs and CRT-D
Feature | Implantable Cardioverter Defibrillator (ICD) | October 25, 2016 | Dave Fornell

October 25, 2016 — St. Jude Medical is recalling 251,346 of its Fortify, Unify and Assura implantable cardioverter...

Medtronic, FDA approval, MRI, MR-conditional scanning, cardiac devices
Technology | EP Lab | October 13, 2016

October 13, 2016 — Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval...

European Heart Rhythm Association, EHRA White Book 2016, EP Europace supplement, cardiac rhythm device use, Europe
News | EP Lab | September 27, 2016

September 27, 2016 — In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the...

Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure | September 20, 2016

September 20, 2016 — Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to...

EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT) | September 15, 2016

September 15, 2016 — EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an...

Overlay Init